Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Learn more about Moneysupermarket Group from CEO Peter Duffy in a video
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Peter Duffy is Chief Executive Officer at Moneysupermarket.Com Group PLC.
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Highlights from BLTG Capital Markets Day on June 3, 2020 | Matt Jones, CEO, Blancco Technology Group PLCBLTG:LSE
00:10:00
Leading Innovation: Mary Barra on The David Rubenstein Show
00:10:00
"Navigating ECB Rate Cuts: Strategies for Investor Success"
00:10:00
Building a Business Brokerage: Joe Marley's Journey
00:10:00
Coda Minerals: Advancing Towards Tier One Status with Significant Copper and Cobalt Discoveries in Australia
00:10:00
Powering the Future of AI: Deep Learning Meets High-Performance Computing with Yann LeCun and Bill Dally|Yann LeCun, Chief AI Scientist,Meta
00:10:00
Joe Phillips Discusses Infinity Mining’s Strategic Future and Upcoming Listing | Joe Phillip, Chairman, Infinity Mining Limited.
00:10:00
Transforming Financial Insights: Innovations at swissQuant Group | Dr. Florian Herzog, CEO, swissQuant Group
00:10:00
Quick Guide: How to Perform a Compliance Test on the Air XS Silica Monitor
00:10:00
Our mission is to be a world-class, industry leading organization that creates long term value for our investors and sustains results across market cycles.|Cory Olson,Chief Operating Officer,Rialto Capital, FS Credit Real Estate Income Trust, Inc.
00:10:00
Creating a Family Mission Statement
00:10:00
CEO elaborates on global efforts to enhance early diagnosis of rare hereditary diseases and metabolomics approaches to address diverse patient populations | Dr. Arndt Rolfs, CEO, Centogene NV.